Literature DB >> 1650181

Complete nucleotide and deduced amino acid sequence of human beta 2-glycoprotein I.

A Steinkasserer1, C Estaller, E H Weiss, R B Sim, A J Day.   

Abstract

The nucleotide and complete amino acid sequence for the human beta 2-glycoprotein I (beta 2I) was derived by sequencing the cDNA clone pB2I-1. In addition to the 326 amino acid residues of the mature protein this clone codes for a putative leader peptide and contains sequence representing 5' and 3' untranslated regions. When this amino acid sequence was compared with the previously published primary sequence, three major amino acid substitutions were found, two involving cysteine residues. These substitutions lead to a new alignment of the complement control protein (CCP) repeats present in beta 2I and a prediction of the complete disulphide bond organization. Northern-blot analysis indicates that hepatocytes are a major site of biosynthesis for this protein. A transcription signal of about 1.5 kb was detected by using RNA from HepG2 cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1650181      PMCID: PMC1151245          DOI: 10.1042/bj2770387

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  Structure-function relationships of the complement components.

Authors:  K B Reid; A J Day
Journal:  Immunol Today       Date:  1989-06

2.  The primary structure of rat beta 2-glycoprotein I.

Authors:  Y Aoyama; Y L Chan; I G Wool
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

3.  A strategy for the rapid multiple alignment of protein sequences. Confidence levels from tertiary structure comparisons.

Authors:  G J Barton; M J Sternberg
Journal:  J Mol Biol       Date:  1987-11-20       Impact factor: 5.469

4.  Detecting homology of distantly related proteins with consensus sequences.

Authors:  L Patthy
Journal:  J Mol Biol       Date:  1987-12-20       Impact factor: 5.469

5.  Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation.

Authors:  J Nimpf; H Wurm; G M Kostner
Journal:  Atherosclerosis       Date:  1987-02       Impact factor: 5.162

6.  Effect of the carbohydrate moiety on the secondary structure of beta 2-glycoprotein. I. Implications for the biosynthesis and folding of glycoproteins.

Authors:  M T Walsh; H Watzlawick; F W Putnam; K Schmid; R Brossmer
Journal:  Biochemistry       Date:  1990-07-03       Impact factor: 3.162

7.  DNA-binding proteins in Yoshida ascites tumor fluid.

Authors:  J Kroll; J K Larsen; H Loft; M Ezban; K Wallevik; M Faber
Journal:  Biochim Biophys Acta       Date:  1976-06-15

8.  Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I.

Authors:  J Nimpf; E M Bevers; P H Bomans; U Till; H Wurm; G M Kostner; R F Zwaal
Journal:  Biochim Biophys Acta       Date:  1986-10-29

9.  Disulfide bonds are localized within the short consensus repeat units of complement regulatory proteins: C4b-binding protein.

Authors:  J Janatova; K B Reid; A C Willis
Journal:  Biochemistry       Date:  1989-05-30       Impact factor: 3.162

10.  Secondary structure of a complement control protein module by two-dimensional 1H NMR.

Authors:  P N Barlow; M Baron; D G Norman; A J Day; A C Willis; R B Sim; I D Campbell
Journal:  Biochemistry       Date:  1991-01-29       Impact factor: 3.162

View more
  34 in total

1.  Microheterogeneity of beta-2 glycoprotein I: implications for binding to anionic phospholipids.

Authors:  T A Brighton; Y P Dai; P J Hogg; C N Chesterman
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI.

Authors:  G M Iverson; E J Victoria; D M Marquis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 3.  Antigenic specificities of "antiphospholipid" autoantibodies.

Authors:  R A Roubey
Journal:  Springer Semin Immunopathol       Date:  1994

4.  Characterization of binding of human beta 2-glycoprotein I to cardiolipin.

Authors:  Z Kertesz; B B Yu; A Steinkasserer; H Haupt; A Benham; R B Sim
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

5.  Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.

Authors:  S Hörkkö; E Miller; E Dudl; P Reaven; L K Curtiss; N J Zvaifler; R Terkeltaub; S S Pierangeli; D W Branch; W Palinski; J L Witztum
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

6.  Beta2-glycoprotein I (beta2-GPI) mRNA is expressed by several cell types involved in anti-phospholipid syndrome-related tissue damage.

Authors:  B Caronti; C Calderaro; C Alessandri; F Conti; R Tinghino; G Palladini; G Valesini
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

7.  Studies on specific interaction of beta-2-glycoprotein I with HBsAg.

Authors:  Pu-Jun Gao; Yun-Feng Piao; Xiao-Dong Liu; Li-Ke Qu; Yang Shi; Xiao-Cong Wang; Han-Yi Yang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

8.  Plasmin-cleaved beta-2-glycoprotein 1 is an inhibitor of angiogenesis.

Authors:  Taro Sakai; Krishnakumar Balasubramanian; Sourindra Maiti; Jyotsna B Halder; Alan J Schroit
Journal:  Am J Pathol       Date:  2007-09-14       Impact factor: 4.307

Review 9.  Annexin A2: biology and relevance to the antiphospholipid syndrome.

Authors:  E Cockrell; R G Espinola; K R McCrae
Journal:  Lupus       Date:  2008-10       Impact factor: 2.911

10.  Expression of anticardiolipin cofactor, human beta 2-glycoprotein I, by a recombinant baculovirus/insect cell system.

Authors:  M Igarashi; E Matsuura; Y Igarashi; H Nagae; Y Matsuura; K Ichikawa; T Yasuda; D R Voelker; T Koike
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.